AIABF yields 1538.46% · PFE yields 6.13%● Live data
📍 AIABF pulled ahead of the other in Year 1
Combined, AIABF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AIABF + PFE for your $10,000?
Capital A Berhad, an investment holding company, provides air transportation services in Malaysia, Indonesia, the Philippines, and internationally under the AirAsia brand. It also offers management, engineering, tour operating, aircraft leasing, shared and outsourcing, central depository, financial and other related, event ticketing, and consultancy services, as well as services in the areas of information technology design, development, and implementation; facilitates business transactions for AirAsia Group with non-resident goods and service providers; and trades in coffee and tea related products, and multimedia content and equipment. In addition, the company provides inflight meal products; manages customer loyalty points; wholesales meat, fish, fruits, vegetables, flowers, and plants; offers online retail sales, inflight magazine content, inflight shop, aviation and commercial, airport related, food and beverages, and research and development services, as well as supporting services to air transport; and operates AirAsia Superapp. Further, it is involved in the marketing and development of loyalty programs; development of software for cybersecurity; and provision of media content, e-hailing, online food ordering, delivery, investment management, and cargo services, as well as provides logistic and payment services for cross border e-commerce marketing. The company was formerly known as AirAsia Group Berhad and changed its name to Capital A Berhad in January 2022. Capital A Berhad was founded in 2001 and is headquartered in Kuala Lumpur, Malaysia.
Full AIABF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.